{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:07:36Z","timestamp":1790150856974,"version":"4.0.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH112861"],"award-info":[{"award-number":["R01MH112861"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01MH098188"],"award-info":[{"award-number":["K01MH098188"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["NARSAD Young Investigator"],"award-info":[{"award-number":["NARSAD Young Investigator"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antidepressants that target monoaminergic systems, such as selective serotonin reuptake inhibitors (SSRIs), are widely used to treat neuropsychiatric disorders including major depressive disorder, several anxiety disorders, and obsessive-compulsive disorder. However, these treatments are not ideal because only a subset of patients achieve remission. The reasons why some individuals remit to antidepressant treatments while others do not are unknown. Here, we developed a paradigm to assess antidepressant treatment resistance in mice. Exposure of male C57BL\/6J mice to either chronic corticosterone administration or chronic social defeat stress induces maladaptive affective behaviors. Subsequent chronic treatment with the SSRI fluoxetine reverses these maladaptive affective behavioral changes in some, but not all, of the mice, permitting stratification into persistent responders and non-responders to fluoxetine. We found several differences in expression of Activin signaling-related genes between responders and non-responders in the dentate gyrus (DG), a region that is critical for the beneficial behavioral effects of fluoxetine. Enhancement of Activin signaling in the DG converted behavioral non-responders into responders to fluoxetine treatment more effectively than commonly used second-line antidepressant treatments, while inhibition of Activin signaling in the DG converted responders into non-responders. Taken together, these results demonstrate that the behavioral response to fluoxetine can be bidirectionally modified via targeted manipulations of the DG and suggest that molecular- and neural circuit-based modulations of DG may provide a new therapeutic avenue for more effective antidepressant treatments.<\/jats:p>","DOI":"10.1038\/s41398-020-01156-y","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T15:03:40Z","timestamp":1610031820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dentate gyrus activin signaling mediates the antidepressant response"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0483-7161","authenticated-orcid":false,"given":"Mark M.","family":"Gergues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Yohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Bharadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-1503","authenticated-orcid":false,"given":"Marjorie R.","family":"Levinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-0376","authenticated-orcid":false,"given":"Benjamin Adam","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095\u20133105 (2003).","journal-title":"JAMA"},{"key":"1156_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","volume":"9","author":"D Warden","year":"2007","unstructured":"Warden, D., Rush, A. J., Trivedi, M. H., Fava, M. & Wisniewski, S. R. The STAR*D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9, 449\u2013459 (2007).","journal-title":"Curr. Psychiatry Rep."},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi, M. H. et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. The. Am. J. psychiatry 163, 28\u201340 (2006).","journal-title":"Am. J. psychiatry"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","volume":"11","author":"WC Drevets","year":"2001","unstructured":"Drevets, W. C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11, 240\u2013249 (2001).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler, E. J. et al. Neurobiology of depression. Neuron 34, 13\u201325 (2002).","journal-title":"Neuron"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/npp.2013.5","volume":"38","author":"M Boldrini","year":"2013","unstructured":"Boldrini, M. et al. Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression. Neuropsychopharmacology 38, 1068\u20131077 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1156_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopsych.2014.06.018","volume":"77","author":"MT Treadway","year":"2015","unstructured":"Treadway, M. T. et al. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol. Psychiatry 77, 285\u2013294 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/nn.4116","volume":"18","author":"BA Samuels","year":"2015","unstructured":"Samuels, B. A. et al. 5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response. Nat. Neurosci. 18, 1606\u20131616 (2015).","journal-title":"Nat. Neurosci."},{"key":"1156_CR9","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg, J. E., Eisch, A. J., Nestler, E. J. & Duman, R. S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104\u20139110 (2000).","journal-title":"J. Neurosci."},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1523\/JNEUROSCI.3632-07.2008","volume":"28","author":"J-W Wang","year":"2008","unstructured":"Wang, J.-W., David, D. J., Monckton, J. E., Battaglia, F. & Hen, R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J. Neurosci. 28, 1374\u20131384 (2008).","journal-title":"J. Neurosci."},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli, L. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805\u2013809 (2003).","journal-title":"Science"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuron.2008.06.023","volume":"59","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59, 399\u2013412 (2008).","journal-title":"Neuron"},{"key":"1156_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","volume":"62","author":"DJ David","year":"2009","unstructured":"David, D. J. et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression. Neuron 62, 479\u2013493 (2009).","journal-title":"Neuron"},{"key":"1156_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1144400","volume":"317","author":"RD Airan","year":"2007","unstructured":"Airan, R. D. et al. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317, 819\u2013823 (2007).","journal-title":"Science"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41591-018-0002-1","volume":"24","author":"S Yun","year":"2018","unstructured":"Yun, S. et al. Stimulation of entorhinal cortex-dentate gyrus circuitry is antidepressive. Nat. Med. 24, 658\u2013666 (2018).","journal-title":"Nat. Med."},{"key":"1156_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2012.12.038","volume":"77","author":"MA Kheirbek","year":"2013","unstructured":"Kheirbek, M. A. et al. Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 77, 955\u2013968 (2013).","journal-title":"Neuron"},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41586-018-0262-4","volume":"559","author":"C Anacker","year":"2018","unstructured":"Anacker, C. et al. Hippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus. Nature 559, 98\u2013102 (2018).","journal-title":"Nature"},{"key":"1156_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8062","volume":"6","author":"RC Bagot","year":"2015","unstructured":"Bagot, R. C. et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat. Commun. 6, 7062 (2015).","journal-title":"Nat. Commun."},{"key":"1156_CR19","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.ynstr.2020.100257","volume":"13","author":"CN Yohn","year":"2020","unstructured":"Yohn, C. N. et al. Behavioral response to fluoxetine in both female and male mice is modulated by dentate gyrus granule cell activity. Neurobiol. Stress 13, 100257 (2020).","journal-title":"Neurobiol. Stress"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.neuron.2017.06.044","volume":"95","author":"L Medrihan","year":"2017","unstructured":"Medrihan, L. et al. Initiation of behavioral response to antidepressants by cholecystokinin neurons of the dentate gyrus. Neuron 95, 564\u2013576 e564 (2017).","journal-title":"Neuron"},{"key":"1156_CR21","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1523\/JNEUROSCI.5155-04.2005","volume":"25","author":"AL Dow","year":"2005","unstructured":"Dow, A. L., Russell, D. S. & Duman, R. S. Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J. Neurosci. 25, 4908\u20134916 (2005).","journal-title":"J. Neurosci."},{"key":"1156_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.104","volume":"2","author":"K Ganea","year":"2012","unstructured":"Ganea, K. et al. Convergent animal and human evidence suggests the activin\/inhibin pathway to be involved in antidepressant response. Transl. Psychiatry 2, e177 (2012).","journal-title":"Transl. Psychiatry"},{"key":"1156_CR23","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","volume":"22","author":"Y Shirayama","year":"2002","unstructured":"Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S. & Duman, R. S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251\u20133261 (2002).","journal-title":"J. Neurosci."},{"key":"1156_CR24","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1073\/pnas.0610282104","volume":"104","author":"JL Warner-Schmidt","year":"2007","unstructured":"Warner-Schmidt, J. L. & Duman, R. S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl Acad. Sci. USA 104, 4647\u20134652 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1156_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coph.2007.10.013","volume":"8","author":"JL Warner-Schmidt","year":"2008","unstructured":"Warner-Schmidt, J. L. & Duman, R. S. VEGF as a potential target for therapeutic intervention in depression. Curr. Opin. Pharm. 8, 14\u201319 (2008).","journal-title":"Curr. Opin. Pharm."},{"key":"1156_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massague","year":"1998","unstructured":"Massague, J. TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753\u2013791 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"1156_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001869","volume":"3","author":"H Ageta","year":"2008","unstructured":"Ageta, H. et al. Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS ONE 3, e1869 (2008).","journal-title":"PLoS ONE"},{"key":"1156_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0091-3057(82)90053-3","volume":"16","author":"RJ Katz","year":"1982","unstructured":"Katz, R. J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharm. Biochem Behav. 16, 965\u2013968 (1982).","journal-title":"Pharm. Biochem Behav."},{"key":"1156_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90\u2013110 (2005).","journal-title":"Neuropsychobiology"},{"key":"1156_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF00187257","volume":"93","author":"P Willner","year":"1987","unstructured":"Willner, P., Towell, A., Sampson, D., Sophokleous, S. & Muscat, R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl.) 93, 358\u2013364. (1987).","journal-title":"Psychopharmacology (Berl.)"},{"key":"1156_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.biopsych.2008.02.022","volume":"64","author":"A Surget","year":"2008","unstructured":"Surget, A. et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293\u2013301 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1156_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2011.02.017","volume":"61","author":"BA Samuels","year":"2011","unstructured":"Samuels, B. A. et al. Modeling treatment-resistant depression. Neuropharmacology 61, 408\u2013413 (2011).","journal-title":"Neuropharmacology"},{"key":"1156_CR33","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1120972","volume":"311","author":"O Berton","year":"2006","unstructured":"Berton, O. et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864\u2013868 (2006).","journal-title":"Science"},{"key":"1156_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nn1659","volume":"9","author":"NM Tsankova","year":"2006","unstructured":"Tsankova, N. M. et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519\u2013525 (2006).","journal-title":"Nat. Neurosci."},{"key":"1156_CR35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan, V. & Nestler, E. J. The molecular neurobiology of depression. Nature 455, 894\u2013902 (2008).","journal-title":"Nature"},{"key":"1156_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1037\/0735-7044.120.2.249","volume":"120","author":"P Ardayfio","year":"2006","unstructured":"Ardayfio, P. & Kim, K.-S. Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav. Neurosci. 120, 249\u2013256 (2006).","journal-title":"Behav. Neurosci."},{"key":"1156_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","volume":"63","author":"SL Gourley","year":"2008","unstructured":"Gourley, S. L. et al. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 63, 353\u2013359 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1156_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1196\/annals.1410.076","volume":"1148","author":"SL Gourley","year":"2008","unstructured":"Gourley, S. L., Wu, F. J. & Taylor, J. R. Corticosterone regulates pERK1\/2 map kinase in a chronic depression model. Ann. N. Y Acad. Sci. 1148, 509\u2013514 (2008).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1156_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2008.01.014","volume":"583","author":"F Murray","year":"2008","unstructured":"Murray, F., Smith, D. W. & Hutson, P. H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharm. 583, 115\u2013127 (2008).","journal-title":"Eur. J. Pharm."},{"key":"1156_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00213-017-4552-6","volume":"234","author":"DA Slattery","year":"2017","unstructured":"Slattery, D. A. & Cryan, J. F. Modelling depression in animals: at the interface of reward and stress pathways. Psychopharmacology (Berl.) 234, 1451\u20131465 (2017).","journal-title":"Psychopharmacology (Berl.)"},{"key":"1156_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085136","volume":"9","author":"BA Samuels","year":"2014","unstructured":"Samuels, B. A. et al. Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors. PLoS ONE 9, e85136 (2014).","journal-title":"PLoS ONE"},{"key":"1156_CR42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nprot.2011.361","volume":"6","author":"SA Golden","year":"2011","unstructured":"Golden, S. A., Covington, H. E. 3rd, Berton, O. & Russo, S. J. A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183\u20131191 (2011).","journal-title":"Nat. Protoc."},{"key":"1156_CR43","doi-asserted-by":"crossref","unstructured":"Samuels, B. A. & Hen, R. in Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests Vol. II, 107\u2013121 (Humana Press, Totowa, NJ, USA, 2011).","DOI":"10.1007\/978-1-61779-313-4_7"},{"key":"1156_CR44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","volume":"87","author":"R Al-Hasani","year":"2015","unstructured":"Al-Hasani, R. et al. Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 87, 1063\u20131077 (2015).","journal-title":"Neuron"},{"key":"1156_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jneumeth.2011.01.019","volume":"197","author":"JP Guilloux","year":"2011","unstructured":"Guilloux, J. P., Seney, M., Edgar, N. & Sibille, E. Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J. Neurosci. Methods 197, 21\u201331 (2011).","journal-title":"J. Neurosci. Methods"},{"key":"1156_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1037\/pha0000112","volume":"25","author":"M Mekiri","year":"2017","unstructured":"Mekiri, M., Gardier, A. M., David, D. J. & Guilloux, J. P. Chronic corticosterone administration effects on behavioral emotionality in female c57bl6 mice. Exp. Clin. Psychopharmacol. 25, 94\u2013104 (2017).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"1156_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF01244819","volume":"88","author":"J Maj","year":"1992","unstructured":"Maj, J. & Moryl, E. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J. Neural Transm. Gen. Sect. 88, 143\u2013156 (1992).","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"1156_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pbb.2014.06.005","volume":"124","author":"PP Kale","year":"2014","unstructured":"Kale, P. P. & Addepalli, V. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharm. Biochem. Behav. 124, 238\u2013244 (2014).","journal-title":"Pharm. Biochem. Behav."},{"key":"1156_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1017\/S1461145708008766","volume":"12","author":"E Berrocoso","year":"2009","unstructured":"Berrocoso, E. & Mico, J. A. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice. Int. J. Neuropsychopharmacol. 12, 61\u201371 (2009).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1156_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4088\/JCP.v59n0702","volume":"59","author":"DA Gilbert","year":"1998","unstructured":"Gilbert, D. A. et al. Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. J. Clin. Psychiatry 59, 345\u2013351 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"1156_CR51","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"1156_CR52","first-page":"627","volume":"23","author":"AJ Rush","year":"2009","unstructured":"Rush, A. J. et al. STAR*D: revising conventional wisdom. CNS drugs 23, 627\u2013647 (2009).","journal-title":"CNS drugs"},{"key":"1156_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351\u2013354 (2000).","journal-title":"Biol. Psychiatry"},{"key":"1156_CR54","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate, C. A. et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856\u2013864 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1156_CR55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/mp.2013.130","volume":"19","author":"G Sanacora","year":"2014","unstructured":"Sanacora, G. et al. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects. Mol. Psychiatry 19, 978\u2013985 (2014).","journal-title":"Mol. Psychiatry"},{"key":"1156_CR56","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","volume":"63","author":"ML Furey","year":"2006","unstructured":"Furey, M. L. & Drevets, W. C. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch. Gen. Psychiatry 63, 1121\u20131129 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1156_CR57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.pharmthera.2009.05.008","volume":"123","author":"WA Carlezon Jr.","year":"2009","unstructured":"Carlezon, W. A. Jr., Beguin, C., Knoll, A. T. & Cohen, B. M. Kappa-opioid ligands in the study and treatment of mood disorders. Pharm. Ther. 123, 334\u2013343 (2009).","journal-title":"Pharm. Ther."},{"key":"1156_CR58","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/npp.2017.60","volume":"42","author":"BA Samuels","year":"2017","unstructured":"Samuels, B. A. et al. The behavioral effects of the antidepressant tianeptine require the mu-opioid receptor. Neuropsychopharmacology 42, 2052\u20132063 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"1156_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","volume":"65","author":"MS Fanselow","year":"2010","unstructured":"Fanselow, M. S. & Dong, H. W. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65, 7\u201319 (2010).","journal-title":"Neuron"},{"key":"1156_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","volume":"163","author":"DG Amaral","year":"2007","unstructured":"Amaral, D. G., Scharfman, H. E. & Lavenex, P. The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Prog. Brain Res. 163, 3\u201322. (2007).","journal-title":"Prog. Brain Res."},{"key":"1156_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1242\/dev.091769","volume":"142","author":"S Pauklin","year":"2015","unstructured":"Pauklin, S. & Vallier, L. Activin\/Nodal signalling in stem cells. Development 142, 607\u2013619 (2015).","journal-title":"Development"},{"key":"1156_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-12-385961-7.00009-3","volume":"85","author":"H Ageta","year":"2011","unstructured":"Ageta, H. & Tsuchida, K. Multifunctional roles of activins in the brain. Vitam. Horm. 85, 185\u2013206 (2011).","journal-title":"Vitam. Horm."},{"key":"1156_CR63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/0306-4522(95)00245-E","volume":"69","author":"K Andreasson","year":"1995","unstructured":"Andreasson, K. & Worley, P. F. Induction of beta-A activin expression by synaptic activity and during neocortical development. Neuroscience 69, 781\u2013796 (1995).","journal-title":"Neuroscience"},{"key":"1156_CR64","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1101\/lm.16659010","volume":"17","author":"H Ageta","year":"2010","unstructured":"Ageta, H. et al. Activin plays a key role in the maintenance of long-term memory and late-LTP. Learn Mem. 17, 176\u2013185 (2010).","journal-title":"Learn Mem."},{"key":"1156_CR65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnmol.2016.00032","volume":"9","author":"AS Link","year":"2016","unstructured":"Link, A. S., Zheng, F. & Alzheimer, C. Activin signaling in the pathogenesis and therapy of neuropsychiatric diseases. Front Mol. Neurosci. 9, 32 (2016).","journal-title":"Front Mol. Neurosci."},{"key":"1156_CR66","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1007\/s12035-015-9363-3","volume":"53","author":"AS Link","year":"2016","unstructured":"Link, A. S. et al. Kdm6b and Pmepa1 as targets of bioelectrically and behaviorally induced Activin A signaling. Mol. Neurobiol. 53, 4210\u20134225 (2016).","journal-title":"Mol. Neurobiol."},{"key":"1156_CR67","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.mp.4002131","volume":"14","author":"F Zheng","year":"2009","unstructured":"Zheng, F. et al. Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. Mol. Psychiatry 14, 332\u2013346 (2009).","journal-title":"Mol. Psychiatry"},{"key":"1156_CR68","doi-asserted-by":"publisher","first-page":"107780","DOI":"10.1016\/j.neuropharm.2019.107780","volume":"160","author":"CN Yohn","year":"2019","unstructured":"Yohn, C. N. et al. Social instability is an effective chronic stress paradigm for both male and female mice. Neuropharmacology 160, 107780 (2019).","journal-title":"Neuropharmacology"},{"key":"1156_CR69","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/s41386-019-0520-7","volume":"44","author":"CN Yohn","year":"2019","unstructured":"Yohn, C. N. et al. Chronic non-discriminatory social defeat is an effective chronic stress paradigm for both male and female mice. Neuropsychopharmacology 44, 2220\u20132229 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"1156_CR70","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/npp.2017.259","volume":"43","author":"AZ Harris","year":"2018","unstructured":"Harris, A. Z. et al. A novel method for chronic social defeat stress in female mice. Neuropsychopharmacology 43, 1276\u20131283 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"1156_CR71","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/humupd\/dmv058","volume":"22","author":"R Wijayarathna","year":"2016","unstructured":"Wijayarathna, R. & de Kretser, D. M. Activins in reproductive biology and beyond. Hum. Reprod. Update 22, 342\u2013357 (2016).","journal-title":"Hum. Reprod. Update"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01156-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T10:12:46Z","timestamp":1669803166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-01156-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-01156-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/491613","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"7"}}